Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271856 · ClinicalTrials.gov registry record · Phase 2
Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV
A Phase 2 study of HIV, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 177
- Enrollment target
- 1
- Study location
NCT00271856: Completed Phase 2 study of HIV, sponsored by University of California, San Francisco.
NCT00271856 is a Phase 2 study of HIV that has completed, run by University of California, San Francisco. The registered enrollment target is 177 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00271856, a Phase 2 study of HIV, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 177 participants
- Enrollment target
- 1
- Study location
Study Summary
To examine the effects of Mindfulness-Based Stress Reduction (MBSR) and education groups on HIV (Human Immunodeficiency Syndrome) infection. Key outcomes include CD4 and viral load, stress hormones, depression and quality of life.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness-Based Stress Reduction (MBSR)
- BEHAVIORAL HIV-education and self-management workshop
Study Locations (1)
California
- Osher Center for Integrative Medicine - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
What the finished NCT00271856 record still lists
NCT00271856 is an interventional study that assigns participants to a tested intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (60% lower).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness-Based Stress Reduction (MBSR) is the first listed.
NCT00271856 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00271856 about?
NCT00271856 is a clinical study titled "Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV". To examine the effects of Mindfulness-Based Stress Reduction (MBSR) and education groups on HIV (Human Immunodeficiency Syndrome) infection. Key outcomes include CD4 and viral load, stress hormones, depression and quality of life.
What is the current status of trial NCT00271856?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 177 participants. The study started on 2005-05. Estimated completion is 2009-09.
What conditions does trial NCT00271856 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT00271856?
The interventions under investigation include: Mindfulness-Based Stress Reduction (MBSR) (BEHAVIORAL), HIV-education and self-management workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT00271856?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00271856 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00271856's enrollment target sits among peer trials
177 123rd of 303 higher than 181 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Improving Physical Ability and Cellular Senescence Elimination in HIV
RECRUITING · Phase 2
-
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
RECRUITING · Phase 2
-
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
RECRUITING · Phase 2
-
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia